Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Herrlinger

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Der Internist|September 30, 2006
[Disturbances in volume and electrolytes with intestinal and kidney diseases]D M Alscher, K Herrlinger, E F Stange
Deutsche Medizinische Wochenschrift (1946)|February 21, 2003
[Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects]M Schwab, K Herrlinger, E Schaeffeler, et al.
Der Internist|May 8, 2010
[New therapeutic approaches to special diseases of the small intestine]M Schumann, K Herrlinger, M Zeitz, et al.
Zeitschrift Fur Gastroenterologie|April 20, 2004
[The role of defensins in the pathogenesis of chronic-inflammatory bowel disease]M Schmid, K Fellermann, J Wehkamp, et al.
Zeitschrift Fur Gastroenterologie|December 5, 2014
[Azathioprine in Crohn's disease therapy--guidance against the background of recent studies]C Schmidt, K Herrlinger, B Siegmund, et al.
Zentralblatt Fur Chirurgie|September 25, 1998
[Cellular immune reactivity in xenogenic "human-anti-pig" transplant combination]K Herrlinger, V Eckstein, E Westphal, et al.
Alimentary Pharmacology & Therapeutics|November 4, 2004
The new DR-70 immunoassay detects cancer of the gastrointestinal tract: a validation studyA Kerber, J Trojan, K Herrlinger, et al.
The Journal of Clinical Investigation|January 1, 1995
Endogenous adenosine mediates coronary vasodilation during exercise after K(ATP)+ channel blockadeD J Duncker, N S van Zon, T J Pavek, et al.
Alimentary Pharmacology & Therapeutics|March 24, 2009
Clinical trial: cyclophosphamide pulse therapy - a promising therapeutic alternative in refractory Crohn's diseaseK J Schmidt, K Fellermann, P Wellhöner, et al.
Metabolism: Clinical and Experimental|November 25, 2000
Methylenetetrahydrofolate reductase mutation (677C-->T) negatively influences plasma homocysteine response to marginal folate intake in elderly womenG P Kauwell, C E Wilsky, J J Cerda, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Der Internist|September 30, 2006
[Disturbances in volume and electrolytes with intestinal and kidney diseases]D M Alscher, K Herrlinger, E F Stange
Deutsche Medizinische Wochenschrift (1946)|February 21, 2003
[Therapy of chronic inflammatory bowel diseases with azathioprine, 6-mercaptopurine and 6-thioguanine. Clinico-pharmacologic aspects]M Schwab, K Herrlinger, E Schaeffeler, et al.
Der Internist|May 8, 2010
[New therapeutic approaches to special diseases of the small intestine]M Schumann, K Herrlinger, M Zeitz, et al.
Zeitschrift Fur Gastroenterologie|April 20, 2004
[The role of defensins in the pathogenesis of chronic-inflammatory bowel disease]M Schmid, K Fellermann, J Wehkamp, et al.
Zeitschrift Fur Gastroenterologie|December 5, 2014
[Azathioprine in Crohn's disease therapy--guidance against the background of recent studies]C Schmidt, K Herrlinger, B Siegmund, et al.
Zentralblatt Fur Chirurgie|September 25, 1998
[Cellular immune reactivity in xenogenic "human-anti-pig" transplant combination]K Herrlinger, V Eckstein, E Westphal, et al.
Alimentary Pharmacology & Therapeutics|November 4, 2004
The new DR-70 immunoassay detects cancer of the gastrointestinal tract: a validation studyA Kerber, J Trojan, K Herrlinger, et al.
The Journal of Clinical Investigation|January 1, 1995
Endogenous adenosine mediates coronary vasodilation during exercise after K(ATP)+ channel blockadeD J Duncker, N S van Zon, T J Pavek, et al.
Alimentary Pharmacology & Therapeutics|March 24, 2009
Clinical trial: cyclophosphamide pulse therapy - a promising therapeutic alternative in refractory Crohn's diseaseK J Schmidt, K Fellermann, P Wellhöner, et al.
Metabolism: Clinical and Experimental|November 25, 2000
Methylenetetrahydrofolate reductase mutation (677C-->T) negatively influences plasma homocysteine response to marginal folate intake in elderly womenG P Kauwell, C E Wilsky, J J Cerda, et al.
Pageof 3